Name | Value |
---|---|
Revenues | 48.0M |
Cost of Revenue | -54.7M |
Gross Profit | 102.7M |
Operating Expense | 191.2M |
Operating I/L | -88.4M |
Other Income/Expense | 48.8M |
Interest Income | 0.0M |
Pretax | -39.6M |
Income Tax Expense | -0.0M |
Net Income/Loss | -39.6M |
Alphatec Holdings, Inc. is a medical technology company specializing in surgical treatment of spinal disorders. The company offers a range of innovative products including neural information systems, spinal fixation systems, anterior and posterior interbody implants, biologics, and imaging products. These products are designed to enhance surgical outcomes and reduce the risk of nerve injury. Alphatec sells its products through a network of independent distributors and direct sales representatives in the United States, generating revenue through product sales and distribution. With a focus on advancing spinal surgery technologies, the company continues to drive growth and innovation in the medical technology industry.